Post-market surveillance, on autopilot.
MedFortis watches FDA data, recalls, trials and the open market for your devices — continuously — and turns it all into audit-ready evidence in minutes, not weeks.
Surveillance that's complete, continuous, and provable.
The three things a post-market auditor actually checks — handled for you.
Complete
Every external signal in one platform — FDA data, recalls, trials and the open market. No blind spots between databases.
Continuous
Always-on monitoring, not a manual sweep every quarter. You're current by default — never scrambling before an audit.
Provable
A timestamped, tamper-evident evidence trail built as you go — the exact record an auditor asks to see.
One platform for every source you track by hand.
Adverse events
FDA MAUDE injuries & malfunctions, surfaced as they post.
Recalls
Active FDA/EU recall matches, including shadow recalls.
Clinical trials
Investigational or trial-restricted units on the open market.
Price & anomaly
Below-market pricing that signals diverted or fake stock.
Seller networks
Connected & repeat sellers mapped into patterns.
Grey-market listings
Unauthorized listings, AI-verified down to the Rx-only label.
From weeks of manual work to minutes.
Post-market surveillance, answered.
What is post-market surveillance (PMS) software?
How does MedFortis automate FDA and EU MDR surveillance?
Does MedFortis monitor grey-market and unauthorized listings?
Is the evidence audit-ready for 21 CFR Part 11 and EU MDR?
What is a PMS Gap Scan?
Who is MedFortis for?
See what your post-market surveillance is missing.
We'll run MedFortis against your device lines, live, and show you what's surfacing across FDA data, recalls, trials and the open market.
Request your free PMS Gap Scan
Tell us about your device lines and we'll reply within one business day to set it up.